Share

    


Home / Search Results

Search Results

You searched for:

The overall cancer rate among adolescents and young adults is on a gradual increase, thus creating the need for oncology programs geared towards young adults and adolescents.
March is Multiple Myeloma Awareness Month. Learn how ACCC is supporting collaboration among healthcare providers with practical, scalable solutions to the real-world challenges of improving quality care delivery for patients with multiple myeloma.
In 2021, ACCC held a series of focus groups to learn how cancer programs are effectively implementing telehealth to manage symptoms and treatment side effects, deliver psychosocial screening and support services, and provide genetic counseling and testing.
In launching its new campaign, "Transforming Complex To Clear," ACCC brought together expert panelists to discuss effective practices and offer tips to address current barriers to biomarker testing in the community setting.
This study looked at how work motivation can impact career readiness, core self-evaluation, and work personality.
An expert ACCC Steering Committee shares 32 informed treatment and care delivery recommendations for the ideal care of patients with non-small cell lung cancer.
An integrated precision tracking program ensures proper follow-up care and surveillance for survivors of colorectal cancer.
This ACCC education program shares key highlights from a national survey of thoracic surgeons, radiation oncologists, and medical oncologists on the barriers that exist in the ideal management of patients with NSCLC.
ACCC has long highlighted the racial and ethnic disparities that exist in oncology and hematology care delivery to advocate for true health equity for all patients with cancer. Through various programs, ACCC helps teach members of the multidisciplinary cancer care team how they can help patients overcome barriers and disparities in various treatment settings.
The purpose of this study was to assess patient, disease, and medication-related factors that affect the rate of unplanned readmissions before next chemotherapy cycle or within 30 days since last chemotherapy admission in patients with hematologic malignancies.
There remains an overarching need to identify and provide guidance on key issues related to the optimal care of patients with NSCLC across different community cancer programs/settings in the U.S. To address this need, a multiphase project was implemented by ACCC and its partner organizations, with the main goal being to support the optimization of care for patients diagnosed with stage III and IV …
As the COVID-19 pandemic recedes and restrictions loosens for most of the U.S., we'll discuss how patient education has become even more critical during this transition.
Growing knowledge of NSCLC subtypes and molecular biomarkers for this disease has led to changes in how NSCLC is diagnosed and staged.
By Randall A. Oyer, MD For resources on COVID-19 as it applies to the oncology community, please visit ACCC’s continually updated Coronavirus Resource page. ACCC members can also access ACCCExchange, a listserv that allows them to communicate in real time with their colleagues about how the COVID-19 virus is affecting their communities and their patients. As a community-spread disease, coronavirus …
For resources on COVID-19 as it applies to the oncology community, please visit ACCC’s continually updated Coronavirus Resource page. ACCC members can also access ACCCExchange, a listserv that allows them to communicate in real time with their colleagues about how the COVID-19 virus is affecting their communities and their patients. As COVID-19 spreads across the U.S., not everyone will get sick. …